Malin pays €34.5 million for stake in Altan Pharma

11th June, 2015

Irish life sciences company Malin said it has paid €34.5 million for a 65 per cent stake in Altan Pharma.

Altan is a private Irish-headquartered pharmaceutical company which has acquired the GES Group, a privately-held group of Spanish injectable drug companies, for €87.5 million. Altan raised €40 million as part of the funding for the deal.

"Altan is Malin's third Irish operating asset and we look forward to building out the company from its Irish base,"...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader



Unlimited Access for 1 Month, €19.99 Monthly thereafter

Get basic

*New subscribers only

You can cancel any time.



€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.




90 Day Pass

You can cancel any time.

2 Yearly



Unlimited Access for 2 Years

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

Hard Station: the strange world of tech embargoes

More Tech Brian Lloyd 5 months ago

Podcast: CWSI on securing remote workers during lockdown working

Podcast: Avaya on improving connectivity through the crisis

Tinkerer tailors a solution for property owners to save on water bills

More Tech Emmet Ryan 7 months ago